Default: Nature Reviews Cardiology

ISSN: 1759-5002

Journal Home

Journal Guideline

Nature Reviews Cardiology Q1 Unclaimed

Nature Publishing Group United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Nature Reviews Cardiology is a journal indexed in SJR in Cardiology and Cardiovascular Medicine with an H index of 164. It has an SJR impact factor of 6,932 and it has a best quartile of Q1. It has an SJR impact factor of 6,932.

Nature Reviews Cardiology focuses its scope in these topics and keywords: surgery, mitral, valve, access, ablation, coronary, af, lessons, livescan, instent, ...

Type: Journal

Type of Copyright:


Open Access Policy:

Type of publications:

Publication frecuency: -


- €

Inmediate OA


Embargoed OA

- €

Non OA


Nature Reviews Cardiology


SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)




No comments ... Be the first to comment!

Aims and Scope

surgery, mitral, valve, access, ablation, coronary, af, lessons, livescan, instent, inflammasome, infarctionbenefits, hypertensionaffect, concepts, atherosclerosis, drugeluting, distinguished, diseasemyocardial, design, definition, activation, cabg, bloodpressure, biological, bayesian, basic, autoimmune, atherosclerosisthird, assessedtransradial, assessedthe, approach, appraisal, aminothiols, affirmations,

Best articles by citations

Optimizing treatment benefit: individualized therapy or the polypill?

View more

Erratum: Balancing ischaemia and bleeding risks with novel oral anticoagulants

View more

High-dose, prescription omega-3 fatty acids do not prevent recurrent AF

View more

Smart-AV attempts to optimize CRT

View more

Risks and benefits of extended DAPT after stenting

View more

Systems-based approaches to cardiovascular disease

View more

Durable-polymer drug-eluting stents might not lead to very late stent thrombosis

View more

The disconnect between phase II and phase III trials of drugs for heart failure

View more

beta-Blockers - still a trusted ally or time for retirement?

View more

Smartphone-based cardiac rehabilitation - a first RCT

View more

How should the appropriateness of PCI be judged?

View more

Perioperative anticoagulation - are we at 'a bridge too far'?

View more

Women living near to a road at increased risk of sudden cardiac death

View more

Management of hypertension in the elderly

View more

Optimum CPR strategies clarified

View more

Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia

View more

Low-dose aspirin failed to improve cardiovascular outcomes

View more

Myocardial salvage with HDL infusion after infarction

View more

Interaction between NOACs and other drugs increases bleeding risk

View more

Detection of ischaemic heart disease in symptomatic women

View more

TTR and HF in black Americans

View more

Clopidogrel-PPI interaction, an ongoing controversy

View more

Statin therapy in men versus women

View more

Strategies to improve cardiac resynchronization therapy

View more